The Risk Intelligent life sciences company has been saved
The Risk Intelligent life sciences company
"The Risk Intelligent life sciences company" provides practical guidance and real-world examples for how to more effectively address the life science industry’s complex risk matrix.
The need for compliance remains paramount, but organizations can enhance their prospects by adopting the principles of Risk Intelligence to manage risk-taking for reward as proactively as they manage risks to existing assets.
The life sciences industry (pharmaceuticals, biotechnology and medical devices) faces significant risks inherent in the business. Executives and directors must address the continual demands of a multitude of constituents — regulators, investors, partners, insurers, physicians, patients, lawyers, media and others. Meeting these needs adds complexity and heightens risk, and as these risks converge and overlap, management of them becomes simultaneously more difficult and more essential.